You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

METHYLPREDNISOLONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Methylprednisolone, and when can generic versions of Methylprednisolone launch?

Methylprednisolone is a drug marketed by Elkins Sinn, Organon Usa Inc, Amneal, Chartwell Rx, Duramed Pharms Barr, Endo Operations, Heather, Invatech, Jubilant Cadista, Novast Labs, Par Pharm, Praxgen, Sandoz, Tianjin Tianyao, Watson Labs, Zydus Pharms, Epic Pharma Llc, Eugia Pharma, Hong Kong, Sagent Pharms Inc, Teva Pharms Usa, Wilshire Pharms Inc, Abraxis Pharm, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Teva Parenteral, and Tianjin Kingyork. and is included in sixty-nine NDAs.

The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Methylprednisolone

A generic version of METHYLPREDNISOLONE was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METHYLPREDNISOLONE?
  • What are the global sales for METHYLPREDNISOLONE?
  • What is Average Wholesale Price for METHYLPREDNISOLONE?
Drug patent expirations by year for METHYLPREDNISOLONE
Drug Prices for METHYLPREDNISOLONE

See drug prices for METHYLPREDNISOLONE

Drug Sales Revenue Trends for METHYLPREDNISOLONE

See drug sales revenues for METHYLPREDNISOLONE

Recent Clinical Trials for METHYLPREDNISOLONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, AntwerpPhase 3
Kasr El Aini HospitalN/A
Hospital General Universitario de AlicantePhase 4

See all METHYLPREDNISOLONE clinical trials

Pharmacology for METHYLPREDNISOLONE
Medical Subject Heading (MeSH) Categories for METHYLPREDNISOLONE

US Patents and Regulatory Information for METHYLPREDNISOLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 089144-001 Mar 28, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sagent Pharms Inc METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040888-005 Jul 18, 2011 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 214297-001 Jan 21, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 086159-001 Feb 9, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 207667-001 Dec 15, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 086953-001 Jul 22, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.